We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.37B
AUM Growth
-$37.7M
Cap. Flow
-$101M
Cap. Flow %
-7.39%
Top 10 Hldgs %
52.46%
Holding
442
New
190
Increased
173
Reduced
43
Closed
9

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.18%
2 Industrials 3.13%
3 Technology 2.48%
4 Financials 2.44%
5 Energy 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SID icon
401
Companhia Siderúrgica Nacional
SID
$1.43B
$57K ﹤0.01%
+23,174
New +$51.7K
IJJ icon
402
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
$47K ﹤0.01%
+622
New +$46K
MLSS icon
403
Milestone Scientific
MLSS
$34.5M
$47K ﹤0.01%
+37,500
New +$52.4K
VDE icon
404
Vanguard Energy ETF
VDE
$10.1B
$47K ﹤0.01%
522
UMC icon
405
United Microelectronic
UMC
$48.9B
$46K ﹤0.01%
+18,909
New +$38K
ANTX
406
DELISTED
Anthem, Inc.
ANTX
$45K ﹤0.01%
865
DGS icon
407
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.7B
$43K ﹤0.01%
+898
New +$40.8K
KBE icon
408
State Street SPDR S&P Bank ETF
KBE
$1.64B
$43K ﹤0.01%
+975
New +$41.4K
WFT
409
DELISTED
Weatherford International plc
WFT
$43K ﹤0.01%
+10,000
New +$50.8K
AUO
410
DELISTED
AU Optronics Corp
AUO
$43K ﹤0.01%
+10,952
New +$44K
DWX icon
411
State Street SPDR S&P International Dividend ETF
DWX
$521M
$41K ﹤0.01%
+1,030
New +$40.3K
ARLZ
412
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$41K ﹤0.01%
+30,000
New +$43.3K
SRCLP
413
DELISTED
Stericycle, Inc
SRCLP
$32K ﹤0.01%
500
RAS
414
DELISTED
RAIT Financial Trust
RAS
$30K ﹤0.01%
14,534
TFCF
415
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$28K ﹤0.01%
1,015
+590
+139% +$16.7K
XLI icon
416
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$24K ﹤0.01%
+343
New +$22.9K
IXJ icon
417
iShares Global Healthcare ETF
IXJ
$4.11B
$21K ﹤0.01%
+380
New +$20.2K
VAW icon
418
Vanguard Materials ETF
VAW
$3B
$21K ﹤0.01%
168
FM
419
DELISTED
iShares Frontier and Select EM ETF
FM
$21K ﹤0.01%
+705
New +$20.4K
ILCG icon
420
iShares Morningstar Growth ETF
ILCG
$3.1B
$7K ﹤0.01%
+230
New +$6.32K
XLB icon
421
State Street Materials Select Sector SPDR ETF
XLB
$8.64B
$6K ﹤0.01%
+224
New +$5.95K
XLRE icon
422
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
$6K ﹤0.01%
+194
New +$6.21K
IYZ icon
423
iShares US Telecommunications ETF
IYZ
$1.19B
$5K ﹤0.01%
+149
New +$4.93K
ILCV icon
424
iShares Morningstar Value ETF
ILCV
$1.3B
$4K ﹤0.01%
+84
New +$4K
SPYG icon
425
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
$4K ﹤0.01%
144

Similar funds

Ballentine Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Ballentine Partners held 442 positions worth $1.37B, down 2.7% from $1.41B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Ballentine Partners withdrew a net $101M in Q2 2017, closing 9 positions and reducing 43 holdings. Its most notable exit was Vanguard Total Stock Market ETF, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.2% of assets, up from 0.68% a quarter earlier, followed by Industrials and Technology.

Against the trend, Ballentine Partners opened a new position in iShares Select U.S. REIT ETF worth $16.6M.

  • Ballentine Partners's largest Q2 2017 buy was iShares Select U.S. REIT ETF: 328,202 shares worth $16.6M.
  • Ballentine Partners added most to UBS E-TRACS Alerian MLP Infrastructure ETN in Q2 2017, an estimated $29.2M increase.
  • Ballentine Partners's biggest Q2 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.93M.
  • Ballentine Partners fully exited Vanguard Total Stock Market ETF in Q2 2017, selling an estimated $394M.
  • Ballentine Partners's ten largest holdings make up 52% of its $1.37B portfolio in Q2 2017.
  • Ballentine Partners opened 190 new positions and closed 9 in Q2 2017.
  • Ballentine Partners's portfolio value fell 2.7% quarter-over-quarter to $1.37B.

Based on Ballentine Partners's 13F filing for Q2 2017, filed 3 Aug 2017.